Doctor alerts could boost cancer risk screening
NCT ID NCT07335445
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether sending reminders to primary care doctors before patient visits can increase screening for Barrett's esophagus, a condition that raises the risk of esophageal cancer. Researchers will compare screening rates before and after the reminders in 3,000 adults. The goal is to see if a simple nudge can help more at-risk patients get screened.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Screening reminder
What this could lead to
If successful, this could show that simple reminders help doctors screen more patients for Barrett's esophagus, potentially catching cancer risks earlier.
What could go wrong
This is an early-stage study looking at screening rates, not a treatment. It may not prove that reminders actually prevent cancer or improve health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT'S ESOPHAGUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••